AlphaHelix Molecular Diagnostics AB

Equities

LEVBIO

SE0000885501

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
0.32 ^SEK	+3.23%		+23.08%	-21.57%

Apr. 25	Level Bio AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 22	AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Alphahelix Molecular Diagnostics AB Publ Reports Earnings Results for the First Quarter Ended March 31, 2021

April 22, 2021 at 02:30 am EDT

AlphaHelix Molecular Diagnostics AB publ announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was SEK 9.703 million compared to SEK 6.383 million a year ago. Operating income was SEK 1.624 million compared to SEK 856,000 a year ago. Net income was SEK 1.612 million compared to SEK 837,000 a year ago.

Latest news about AlphaHelix Molecular Diagnostics AB

Level Bio AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Third Quarter Ended September 30, 2023	23-10-26	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-20	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-23	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-27	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-21	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-17	CI
Alphahelix Molecular Diagnostics AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-12	CI
Alphahelix Molecular Diagnostics AB Publ Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-22	CI
Alphahelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-02-17	CI
Xanadu Technologies AB, Tataa Biocenter AB and Active Healthtech Nordic AB acquired a 13.17% stake in AlphaHelix Molecular Diagnostics AB from Labkompaniet AB.	20-05-05	CI
AlphaHelix Molecular Diagnostics AB Appoints Peter Herte as Chief Executive Officer, Effective May 23, 2017	17-05-10	CI
AlphaHelix Molecular Diagnostics AB Auditor Raises 'Going Concern' Doubt	13-06-03	CI

Chart AlphaHelix Molecular Diagnostics AB

Duration

Period

Chart AlphaHelix Molecular Diagnostics AB

More charts

Company Profile

Level Bio AB (publ), formerly Alphahelix Molecular Diagnostics publ AB, is a Sweden-based company active in medical technology. The Company conducts research and development of patented technology that enables the identification of viruses and bacteria. Level Bio is the parent company in the group, with operations in the subsidiaries CyberGene and Techtum Lab. CyberGene develops and manufactures diagnostic kits for the clinical market. Techtum Lab is a reputable distributor and full-service partner to molecular biology labs in the Nordics. The products are sold under several brands and via its own distributors, mainly to laboratories and research institutes. The biggest activity is found within the Nordic market. The head office is in Nacka.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
ALPHAHELIX MOLECULAR DIAGNOSTICS AB	-21.57%	1.84M
THERMO FISHER SCIENTIFIC	+12.15%	228B
DANAHER CORPORATION	+14.90%	196B
INTUITIVE SURGICAL, INC.	+18.22%	141B
BOSTON SCIENTIFIC CORPORATION	+29.15%	110B
SIEMENS HEALTHINEERS AG	+0.53%	65.88B
EDWARDS LIFESCIENCES CORPORATION	+16.92%	54.3B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+6.33%	52.39B
AGILENT TECHNOLOGIES, INC.	+10.93%	45.22B
GE HEALTHCARE TECHNOLOGIES INC.	+5.87%	37.12B

Other Advanced Medical Equipment & Technology